NodeAI Diagnostics develops AI-driven tools to improve lung cancer staging by enhancing ultrasound analysis during biopsies.
NodeAI Diagnostics has raised $366K in total funding. The most recent round was Seed. The last funding was announced in May 2026.
NodeAI Diagnostics's investors include Ontario Centre of Innovation.
NodeAI Diagnostics is headquartered in Hamilton, Canada.
NodeAI Diagnostics develops AI-driven tools to improve lung cancer staging by enhancing ultrasound analysis during biopsies.
NodeAI Diagnostics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NodeAI Diagnostics — Funding & Investors." VCBacked, May 11, 2026, https://www.vcbacked.co/company/nodeai-diagnostics. Accessed September 14, 2026.
VCBacked. (2026). NodeAI Diagnostics — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/nodeai-diagnostics
{{cite web |title=NodeAI Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/nodeai-diagnostics |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated